Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 47-57

  Bird, P I ^a  

^a BOX HILL HOSPITAL   (Australia)

Author keywords

Apoptosis; Cathepsin G; Cytotoxicity; Granule; Granzyme B; Leucocyte; M NEI; Phagocytosis; PI 6; PI 9; Serpin

Indexed keywords

CASPASE; CATHEPSIN G; GRANZYME B; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; CYTOTOXIC LYMPHOCYTE; ENZYME ACTIVATION; HOST RESISTANCE; HUMAN; PROTEIN DEGRADATION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CATHEPSINS; CYTOPLASMIC GRANULES; GRANZYMES; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OVALBUMIN; PROTEIN CONFORMATION; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SERPINS;

EID: 0033026169     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00787.x     Document Type: Review

References (96)

1. 1 Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N. Engl. J. Med. 1992; 326: 800-6.
2. 2 Bird PI. Activation and function of protein C and protein S occur as part of a complex network regulating hemostasis and inflammation. Hematol. Rev. 1996; 9: 251-74.
3. 3 Vaux DL, Strasser A. The molecular biology of apoptosis. Proc. Natl Acad. Sci. USA 1996; 93: 2239-44.
4. 4 Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 1996; 88: 386-401.
5. 5 Sheridan JP, Marsters SA, Pitti RM et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277: 818-21.
6. 6 Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.
7. 7 Zhou Q, Snipas S, Orth K, Muzio M, Dixit V, Salvesen G. Target protease specificity of the viral serpin CrmA. J. Biol. Chem. 1997; 272: 7797-800.
8. 8 Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1997; 16: 6914-25.
9. 9 Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
10. 10 Smyth MJ, Trapani JA. Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995; 16: 202-6.
11. 11 Trapani JA. Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. Int. Rev. Cytol. 1998; 182: 111-92.
12. 12 Darmon AJ, Ley TJ, Nicholson DW, Bleackley RC. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J. Biol. Chem. 1996; 271: 21709-12.
13. 13 Froelich CJ, Orth K, Turbov J et al. New paradigm for lymphocyte granule mediated cytotoxicity: Target cells bind and internalize granzyme B but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 1996; 271: 29073-9.
14. 14 Williams MS, Henkart PA. Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 1994; 153: 4247-55.
15. 15 Caughey GH. Serine proteinases of mast cell and leukocyte granules. A league of their own. Am. J. Respir. Crit. Care Med. 1994; 150: S138-42.
16. 16 Polanowska J, Krokosynska I, Czapinska H, Watorek W, Dadlez M, Otlewski J. Specificity of human cathepsin G. Biochim. Biophys. Acta 1998; 1386: 189-98.
17. 17 Ebnet K, Hausmann M, Lehmann-Grube F et al. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 1995; 14: 4230-9.
18. 18 Heussel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-87.
19. 19 Belaaouaj A, McCarthy R, Baumann M et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nature Med. 1998; 4: 615-18.
20. 20 Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem. Sci. 1997; 22: 299-306.
21. 21 Darmon AJ, Bleackley RC. Proteases and cell-mediated toxicity. Crit. Rev. Immunol. 1998; 18: 255-73.
22. 22 Pinkoski MJ, Hobman M, Heibein JA et al. Entry and trafficking of granzyme B in target cells during granzyme B-perforinmediated apoptosis. Blood 1998; 92: 1044-54.
23. 23 Mullbacher A, Ebnet K, Blanden RV et al. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl Acad. Sci. USA 1996; 93: 5783-7.
24. 24 Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-21.
25. 25 Spitznagel JK. Antibiotic proteins of human neutrophils. J. Clin. Invest. 1990; 86: 1381-6.
26. 26 Lehrer RI, Ganz T. Antimicrobial polypeptides of human neutrophils. Blood 1990; 76: 2169-81.
27. 27 Rao NV, Rao GV, Marshall BC, Hoidal JR. Biosynthesis and processing of proteinase 3 in U937 cells. J. Biol. Chem. 1996; 271: 2972-8.
28. 28 Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: Etiology and treatment. Semin. Hematol. 1997; 34: 279-90.
29. 29 Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase 3. FEBS Lett. 1994; 352: 231-5.
30. 30 Chertov O, Ueda H, Xu LL et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 1997; 186: 739-47.
31. 31 Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379-88.
32. 32 Janoff A, Feinstein G, Malemud CJ, Elias JM. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteinases: A model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue. J. Clin. Invest. 1976; 57: 615-24.
33. 33 McDonald JA, Kelley DG. Degradation of fibronectin by human leukocyte elastase. J. Biol. Chem. 1980; 255: 8848-58.
34. 34 Gadek JE, Fells GA, Wright DG, Crystal RG. Human neutrophil elastase functions as a type III collagen 'collagenase'. Biochem. Biophys. Res. Commun. 1980; 95: 1815-22.
35. 35 Mainardi CL, Dixit SN, Kang AH. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J. Biol. Chem. 1980; 255: 5435-41.
36. 36 Janoff A. Elastase in tissue injury. Ann. Rev. Med. 1985; 36: 2207-16.
37. 37 Lee CT, Fein AM, Lippman M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N. Engl. J. Med. 1981; 304: 192-6.
38. 38 Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 1985; 132: 529-35.
39. 39 Weiss SJ. Tissue destruction by neutrophils. N. Engl. J. Med. 1989; 320: 365-76.
40. 40 Laurell C-B, Eriksson S. The electrophoretic alphal-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 1963; 15: 132-40.
41. 41 Zhou Q, Salvesen GS. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem. J. 1997; 324: 361-4.
42. 42 Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: Structure, function and regulation. J. Biol. Chem. 1994; 269: 15 957-60.
43. 43 Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease. Struct. Biol. 1995; 2: 96-113.
44. 44 Patston PA, Gettins PGW, Schapira M. Serpins are suicide substrates: Implications for the regulation of proteolytic pathways. Semin. Thromb. Hemost. 1994; 20: 410-16.
45. 45 Travis J, Salveson GS. Human plasma proteinase inhibitors. Ann. Rev. Biochem. 1983; 52: 655-709.
46. 46 Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. The anticoagulant activation of antithrombin by heparin. Proc. Natl Acad. Sci. USA 1998; 94: 14 683-8.
47. 47 Whisstock J, Skinner R, Lesk AM. An atlas of serpin conformations. Trends Biochem. Sci. 1998; 23: 63-7.
48. 48 Wilczynska M, Fa M, Karolin J, Ohlsson P-I, Johansson LB-A, Ny T. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol. 1997; 4: 354-7.
49. 49 Stratikos E, Gettins PW. Major proteinase movement upon stable serpin-proteinase complex formation. Proc. Natl Acad. Sci. USA 1997; 94: 453-8.
50. 50 Gagliardini V, Fernandez P-A, Lee RK et al. Prevention of vertebrate neuronal cell death by the crmA gene. Science 1994; 263: 826-8.
51. 51 Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homologue of the C.elegans cell death gene ced-3. Cell 1993; 75: 653-60.
52. 52 Remold-O'Donnell E. The ovalbumin family of serpin proteins. FEBS Lett. 1993; 315: 105-8.
53. 53 Schick C, Pemberton PA, Shi G-P et al. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: A kinetic analysis. Biochemistry 1998; 37: 5258-66.
54. 54 Ye RD, Ahern SM, Le Beau MM, Lebo RV, Sadler JE. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J. Biol. Chem. 1989; 264: 5495-502.
55. 55 Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem. Biophys. Res. Commun. 1991; 181: 51-8.
56. 56 Schneider SS, Schick C, Fish KE et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl Acad. Sci. USA 1995; 92: 3147-51.
57. 57 Remold-O'Donnell E, Chin J, Alberts M. Sequence and molecular characterisation of human monocyte/neutrophil elastase inhibitor. Proc. Natl Acad. Sci. USA 1992; 89: 5635-9.
58. 58 Zou Z, Anisowicz A, Hendrix MJC et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-9.
59. 59 Coughlin P, Sun J, Cerruti L, Salem HH, Bird P. Cloning and molecular characterization of a human intracellular proteinase inhibitor. Proc. Natl Acad. Sci. USA 1993; 90: 9417-21.
60. 60 Sprecher CA, Morgenstern KA, Mathewes S et al. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem. 1995; 270: 29 854-61.
61. 61 Sun J, Bird CH, Sutton V et al. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 1996; 271: 27 802-9.
62. 62 Riewald M, Schleef RR. Molecular cloning of bomapin (protease inhibitor 10), a novel human serpin that is expressed specifically in the bone marrow. J. Biol. Chem. 1995; 270: 26 754-7.
63. 63 Tsujimoto M, Tsuruoka N, Ishida N et al. Purification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity. J. Biol. Chem. 1997; 272: 15 373-80.
64. 64 Bartuski AJ, Kamachi Y, Schick C, Overhauser J, Silverman GA Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3. Genomics 1997; 43: 321-8.
65. 65 Coughlin P, Nicholl J, Sun J, Salem H, Bird P, Sutherland G Chromosomal mapping of the human proteinase inhibitor 6 (PI6) gene to 6p25 by fluorescence in situ hybridization. Genomics 1995; 26: 431-3.
66. 66 Scott FL, Coughlin PB, Bird C, Cerruti L, Hayman JA, Bird P. Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J. Biol. Chem. 1996; 271: 1605-12.
67. 67 Ooms L, Nicholl J, Bird P, Sutherland GR. Localization of the human monocyte/neutrophil elastase inhibitor gene to chromosome 6p25. Chromosome Res. 1995; 3: 447.
68. 68 Evans E, Cooley J, Remold-O'Donnell E. Characterization and chromosomal localization of ELANH2, the gene encoding human monocyte/neutrophil elastase inhibitor. Genomics 1995; 28: 235-40.
69. 69 Eyre HJ, Sun J, Sutherland GR, Bird P. Chromosomal mapping of the gene (PI9) encoding the intracellular serpin proteinase inhibitor 9 6p25 by fluorescence in situ hybridization. Genomics 1996; 37: 406-8.
70. 70 Sun J, Stephens R, Mirza G, Kanai H, Ragoussis J, Bird PI. A serpin gene cluster on human chromosome 6p25 contains PI6, PI9 and ELANH2 which have a common structure almost identical to the 18q21 ovalbumin serpin genes. Cytogenet. Cell Genet. 1998 (in press).
71. 71 Belin D. Biology and facultative secretion of plasminogen activator inhibitor-2. Thromb. Haemost. 1993; 70: 144-7.
72. 72 Tschopp J, Thome M, Hofman K, Meinl E. The fight of viruses against apoptosis. Curr. Opin. Genet. Dev. 1998; 8: 82-7.
73. 73 Pickup DJ. Poxviral modifiers of cytokine responses to infection. Infect. Agents Dis. 1994; 3: 116-27.
74. 74 Ray CA, Black RA, Kronheim SR et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1-beta converting enzyme. Cell 1992; 69: 597-604.
75. 75 Komiyama T, Ray CA, Pickup DJ et al. Inhibition of interleukin-1beta converting enzyme by the cowpox virus serpin crmA. J. Biol. Chem. 1994; 269: 19 331-7.
76. 76 Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 1995; 270: 10 377-9.
77. 77 Tewari M, Dixit VM. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol Chem. 1995; 270: 3255-60.
78. 78 Macen JL, Garner RL, Musy PY et al. Differential induction of the Fas-and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifierA/SPI-2 and SPI-1 protein. Proc. Natl Acad. Sci. USA 1996; 93: 9108-13.
79. 79 Atkinson EA, Barry M, Darmon AJ et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J. Biol. Chem. 1998; 273: 21 261-6.
80. 80 Odake S, Kam CM, Narasimhan L et al. Human and murine cytotoxic T lymphocyte serine proteases: Subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry 1991; 30: 2217-27.
81. 81 Bird CH, Sutton VR, Sun J et al. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 1998; 18: 6387-98.
82. 82 Coughlin PB, Tetaz T, Salem HH. Identification and purification of a novel serine proteinase inhibitor. J. Biol. Chem. 1993; 268: 9541-7.
83. 83 Sun J, Coughlin P, Salem H, Bird P. Production and characterization of recombinant human proteinase inhibitor 6 expressed in Pichia pastoris. Biochim. Biophys. Acta 1995; 1252: 28-34.
84. 84 Morgenstern KA, Sprecher C, Holth L et al. Complementary DNA cloning and kinetic characterization of a novel intracellular serine proteinase inhibitor: Mechanism of action with trypsin and factor Xa as model proteinases. Biochemistry 1994; 33: 3432-41.
85. 85 Scott FL, Hirst CE, Sun J, Bottomley SP, Bird CH, Bird PI. The intracellular serpin proteinase inhibitor 6 (PI-6) is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G. Blood (in press).
86. 86 Riewald M, Schleef RR. Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin-like proteinases utilizing distinct reactive site residues. J. Biol. Chem. 1996; 271: 14 526-32.
87. 87 Remold-O'Donnell E, Nixon JC, Rose RM. Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils. J. Exp. Med. 1989; 169: 1071-86.
88. 88 Sugimori T, Cooley J, Hoidal JR, Remold-O'Donnell E. Inhibitory properties of recombinant monocyte/neutrophil elastase inhibitor. Am. J. Respir. Cell Mol. Biol. 1995; 13: 314-22.
89. 89 Brunk UT, Dalen H, Roberg K, Hellquist HB. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 1997; 23: 616-26.
90. 90 Dear AE, Medcalf RL. The cellular and molecular biology of plasminogen activator inhibitor type-2. Fibrinolysis 1995; 9: 321-30.
91. 91 Trapani JA, Smyth MJ, Apostolidis VA, Dawson M, Browne K. Granule serine proteinases are normal nuclear constituents of natural killer cells. J. Biol Chem. 1994; 269: 18 359-65.
92. 92 Nagler-Anderson C, Verret CR, Firmenich AA, Berne M, Eisen HN. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines. J. Immunol. 1988; 141: 3299-305.
93. 93 Golstein P. Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity. Nature 1974; 252: 81-3.
94. 94 Kranz DM, Eisen HN. Resistance of cytotoxic lymphocytes to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl Acad. Sci. USA 1987; 84: 3375-9.
95. 95 Blakely A, Gorman K, Ostergaard H et al. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity. J. Exp. Med. 1987; 166: 1070-83.
96. 96 Liu C-C, Jiang S, Persechini PM, Zychlinsky A, Kaufmann Y, Young JD. Resistance of cytolytic lymphocytes to perforinmediated killing. Induction of resistance correlates with increase in cytotoxicity. J Exp. Med. 1989; 169: 2211-25.